Rybrevant faspro 1,600 MG vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV0S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,330
Award facts
- Contract value 100% obligated
- $33,330.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,330.36 to AmerSourceBergen Drug Corp on January 21, 2026, for the supply of Rybrevant (sotorasib) 1,600 mg vials in 10 mL quantities, with completion scheduled for February 11, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies, particularly the Department of Defense and Veterans Affairs healthcare systems.
This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables AmerSourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. Rybrevant is an FDA-approved targeted cancer therapy used in the treatment of non-small cell lung cancer, reflecting the contractor's role in providing specialized oncology medications and other critical pharmaceuticals to support military medical readiness and veteran healthcare needs. The non-set-aside competitive award demonstrates the contractor's capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26FQV0S?
SPE2DR26FQV0S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FQV0S worth?
The government has obligated $33,330 on SPE2DR26FQV0S.
Is contract SPE2DR26FQV0S an order under another contract?
Yes. SPE2DR26FQV0S is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV0S competed?
The extent of competition for SPE2DR26FQV0S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award